dc.contributor | Departament de Salut |
dc.contributor.author | Garcia, Valentin |
dc.contributor.author | Luna, Alejandro |
dc.contributor.author | Alonso-Dominguez, Juan M. |
dc.contributor.author | Estrada, Natalia |
dc.contributor.author | Boqué-Genovard, Concepción |
dc.contributor.author | Cortes, Montse |
dc.contributor.author | Xicoy, Blanca |
dc.date.accessioned | 2022-02-07T13:53:49Z |
dc.date.available | 2022-02-07T13:53:49Z |
dc.date.issued | 2021-02-09 |
dc.identifier.citation | Garcia-Gutiérrez V, Luna A, Alonso-Dominguez JM, Estrada N, Boque C, Xicoy B, et al. Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice. Blood Cancer J. 2021 Feb 9;11(2):16. |
dc.identifier.issn | 2044-5385 |
dc.identifier.uri | https://hdl.handle.net/11351/6986 |
dc.description | Leucèmia mieloide crònica; Asciminib; Tractament |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation.ispartofseries | Blood Cancer Journal;11(2) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Proteïna quinasa CK2 |
dc.subject | Tiroxina - Inhibidors |
dc.subject | Leucèmia mieloide crònica - Tractament |
dc.subject.mesh | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.subject.mesh | Niacinamide |
dc.title | Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41408-021-00420-8 |
dc.subject.decs | leucemia mielogenosa crónica BCR-ABL positiva |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.subject.decs | niacinamida |
dc.relation.publishversion | https://doi.org/10.1038/s41408-021-00420-8 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Garcia-Gutiérrez V, Luna A] Hematology, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain. [Alonso-Dominguez JM] Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), UAM, Madrid, Spain. [Estrada N, Xicoy B] Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain. [Boque C] Institut Català d’Oncologia – L’Hospitalet de Llobregat, L’Hospitalet de Llobregat, Spain. [Cortes M] Hospital General de Granollers, Granollers, Spain |
dc.identifier.pmid | 33563899 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |